BioStem Technologies BSEM Estimates

NASDAQ BSEM
$1.47 +0.43 (+41.35%)
At close: Nov 11, 2026 · 4:00 PM EST
Analyst Estimates

BioStem Technologies, Inc. Quarterly Revenue Estimates

Periods 12
Next Period Q3 26
Consensus 6.92 M

Analysts expect BioStem Technologies, Inc. to report revenue of 6.92 M for Q3 26, against a range of 6.32 M to 7.53 M. The most recent reported quarter, Q2 26, came in at 7.90 M, a 17.0% beat against the 6.75 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) 82.56 M102.87 M72.50 M49.30 M10.47 M10.10 M6.14 M7.90 M----
High Estimate 86.78 M95.98 M100.08 M85.66 M57.21 M62.78 M5.97 M7.39 M7.53 M7.62 M10.40 M12.10 M
Low Estimate 75.11 M84.92 M90.14 M74.63 M47.96 M53.32 M5.20 M6.12 M6.32 M6.76 M9.07 M11.01 M
Consensus Estimate 80.94 M90.45 M95.11 M80.14 M52.59 M58.05 M5.58 M6.75 M6.92 M7.19 M9.73 M11.55 M
Analyst Estimates

BioStem Technologies, Inc. Quarterly Earnings Per Share (EPS) Estimates

Periods 12
Next Period Q3 26
Consensus -0.42

Analysts expect BioStem Technologies, Inc. to report earnings per share of -0.42 for Q3 26, against a range of -0.44 to -0.40. The most recent reported quarter, Q2 26, came in at -0.52, a 8.3% miss against the -0.48 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) 0.320.940.17-0.030.03-0.67-0.52-0.52----
High Estimate 0.350.431.290.320.000.02-0.25-0.45-0.40-0.45-0.37-0.29
Low Estimate 0.330.351.150.280.000.02-0.29-0.51-0.44-0.51-0.41-0.35
Consensus Estimate 0.340.391.220.300.000.02-0.27-0.48-0.42-0.48-0.39-0.32

BioStem Technologies, Inc. Estimates API

Pull Wall Street consensus for BioStem Technologies, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=BSEM&mode=revenue&api_key=YOUR_API_KEY